(Q46747924)

English

Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

Adaptive radiation therapy

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Christine Sempoux

19

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

Vincent M Remouchamps

object named as

V Remouchamps

10

0 references

author name string

J-P Machiels

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

L Duck

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

B Honhon

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

B Coster

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

J-C Coche

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

P Scalliet

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

Y Humblet

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

S Aydin

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

J Kerger

9

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

J-L Canon

11

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

P Van Maele

12

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

L Gilbeau

13

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

S Laurent

14

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

C Kirkove

15

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

M Octave-Prignot

16

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

J-F Baurain

17

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

A Kartheuser

18

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

publication date

11 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

16

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

12

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

1898-1905

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI406

21 January 2018

Improved survival and reduction in local failure rates after preoperative radiotherapy: evidence for the generalizability of the results of Swedish Rectal Cancer Trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI406

21 January 2018

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI406

21 January 2018

Effective surgical adjuvant therapy for high-risk rectal carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI406

21 January 2018

Sphincter preservation therapy for distal rectal carcinoma: a review

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI406

21 January 2018

Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI406

21 January 2018

Preoperative versus postoperative chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI406

21 January 2018

Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI406

21 January 2018

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI406

21 January 2018

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI406

21 January 2018

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI406

21 January 2018

XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI406

21 January 2018

Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI406

21 January 2018

Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI406

21 January 2018

Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI406

21 January 2018

Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI406

21 January 2018

Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: Phase I and II studies.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI406

21 January 2018

Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI406

21 January 2018

Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3-T4 unresectable rectal cancer: a phase II IATTGI study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI406

21 January 2018

Phase I trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI406

21 January 2018

Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI406

21 January 2018

Identifiers

10.1093/ANNONC/MDI406

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16219623

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46747924&oldid=2129645013"